Literature DB >> 32229188

Cancer immunotherapy: Current applications and challenges.

Jin-Yu Sun1, Xiao-Jie Lu2.   

Abstract

Mesh：

Substances：

Year:  2020        PMID： 32229188     DOI： 10.1016/j.canlet.2020.03.024

Source DB:  PubMed          Journal:  Cancer Lett        ISSN： 0304-3835            Impact factor:   8.679


× No keyword cloud information.
  8 in total

1.  Targeting depletion of myeloid-derived suppressor cells potentiates PD-L1 blockade efficacy in gastric and colon cancers.

Authors:  Yao Tang; Cong Zhou; Qingli Li; Xiaojiao Cheng; Tinglei Huang; Fuli Li; Lina He; Baiweng Zhang; Shuiping Tu
Journal:  Oncoimmunology       Date:  2022-10-13       Impact factor: 7.723

Review 2.  Gut Microbiota: A Promising Milestone in Enhancing the Efficacy of PD1/PD-L1 Blockade Therapy.

Authors:  Yuqing Zhou; Zhaoxia Liu; Tingtao Chen
Journal:  Front Oncol       Date:  2022-02-16       Impact factor: 6.244

Review 3.  Three-dimensional (3D) scaffolds as powerful weapons for tumor immunotherapy.

Authors:  Shuyan Han; Jun Wu
Journal:  Bioact Mater       Date:  2022-01-26

Review 4.  Key Players of the Immunosuppressive Tumor Microenvironment and Emerging Therapeutic Strategies.

Authors:  Kevin Park; Mysore S Veena; Daniel Sanghoon Shin
Journal:  Front Cell Dev Biol       Date:  2022-03-08

5.  Inflammatory and autoimmune predictive markers of response to anti-PD-1/PD-L1 therapy in NSCLC and melanoma.

Authors:  Aram A Musaelyan; Sergey V Lapin; Margarita A Urtenova; Svetlana V Odintsova; Ivan V Chistyakov; Andrey M Ulitin; Andrey L Akopov; Sergey V Orlov
Journal:  Exp Ther Med       Date:  2022-07-05       Impact factor: 2.751

6.  Cardiovascular Toxicity With PD-1/PD-L1 Inhibitors in Cancer Patients: A Systematic Review and Meta-Analysis.

Authors:  Surui Liu; Wei Gao; Yan Ning; Xiaomeng Zou; Weike Zhang; Liangjie Zeng; Jie Liu
Journal:  Front Immunol       Date:  2022-07-08       Impact factor: 8.786

Review 7.  Improving the synergistic combination of programmed death-1/programmed death ligand-1 blockade and radiotherapy by targeting the hypoxic tumour microenvironment.

Authors:  Faiqa Mudassar; Han Shen; Kristina M Cook; Eric Hau
Journal:  J Med Imaging Radiat Oncol       Date:  2022-04-24       Impact factor: 1.667

Review 8.  Neutrophils: Musketeers against immunotherapy.

Authors:  Kashif Rafiq Zahid; Umar Raza; Soumya Tumbath; Lingxiang Jiang; Wenjuan Xu; Xiumei Huang
Journal:  Front Oncol       Date:  2022-08-25       Impact factor: 5.738
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.